κ light chain-expressing hematogones in a patient with λ-restricted CLL and multiple myeloma on daratumumab therapy

Blood. 2022 Oct 27;140(17):1917. doi: 10.1182/blood.2022017943.
No abstract available

MeSH terms

  • Humans
  • Immunoglobulin kappa-Chains
  • Immunoglobulin lambda-Chains
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Leukemia, Lymphocytic, Chronic, B-Cell* / genetics
  • Multiple Myeloma* / drug therapy
  • Multiple Myeloma* / genetics

Substances

  • daratumumab
  • Immunoglobulin kappa-Chains
  • Immunoglobulin lambda-Chains